Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Breast Neoplasms 8Prostatic Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Osteoporosis 3Polycystic Ovary Syndrome 2Obesity 2Neoplasm Metastasis 2Lymphoma 2Leukemia 2Bone Diseases, Metabolic 2Vitamin D Deficiency 1Sexual Dysfunction, Physiological 1Psoriasis 1Pain 1Osteoarthritis 1Neoplasms 1Multiple Myeloma 1Melanoma, Cutaneous Malignant 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Insulin Resistance 1Inflammation 1Hypertension 1Giant Cell Tumor of Bone 1Gastrointestinal Neoplasms 1

Interventions

Zoledronic Acid 3Risedronic Acid 3Denosumab 3Vitamin D 2Letrozole 2Calcium 2Nutrition Assessment 1Ibandronic Acid 1Geritol 1Calcium Carbonate 1Aromatase Inhibitors 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Bone Diseases, Metabolic × Vitamin D × Clear all
NCT00452439 2020-12-28

A Study of Actonel for the Prevention of Bone Loss

M.D. Anderson Cancer Center

Phase 3 Completed
72 enrolled 8 charts
LymphoidOther hematologic neoplasm

Bone Diseases, Metabolic, Leukemia, Lymphoma, Osteoporosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00352846 2013-07-02

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

M.D. Anderson Cancer Center

Phase 3 Completed
135 enrolled 4 charts
Lymphoid

Bone Diseases, Metabolic, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡